Are you Dr. Tokuhisa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
508 Fulton St
Durham, NC 27705Phone+1 919-286-0411
Publications & Presentations
PubMed
- 14 citationsTargeting n-cadherin increases vascular permeability and differentially activates akt in melanomaRyan S. Turley, Yoshihiro Tokuhisa, Hiroaki Toshimitsu, Michael E. Lidsky, James C. Padussis
Annals of Surgery. 2015-02-01 - 40 citationsBevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Andrew N. Fontanella, James C. Padussis, Hiroaki Toshimitsu, Yoshihiro Tokuhisa
Clinical Cancer Research. 2012-06-15 - 4 citationsSRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma.Yoshihiro Tokuhisa, Michael E. Lidsky, Hiroaki Toshimitsu, Ryan S. Turley, Georgia M. Beasley
Annals of Surgical Oncology. 2014-03-01
